Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Discovery of compounds with viscosity-reducing effects on biopharmaceutical formulations with monoclonal antibodies. Local targets link to admitted publications; unresolved targets remain external evidence.
Molecular basis of high viscosity in concentrated antibody solutions: Strategies for high concentration drug product development
10.1080/19420862.2015.1128606 · 2016 · External reference
Intermolecular Interactions and the Viscosity of Highly Concentrated Monoclonal Antibody Solutions
10.1007/s11095-015-1690-6 · 2015 · External reference
Safety of switching from intravenous to subcutaneous rituximab during first-line treatment of patients with non-Hodgkin lymphoma: the Spanish population of the MabRella study
10.1111/bjh.16227 · 2020 · External reference
Viscosity-Lowering Effect of Amino Acids and Salts on Highly Concentrated Solutions of Two IgG1 Monoclonal Antibodies
10.1021/acs.molpharmaceut.5b00643 · 2015 · External reference
Contrasting the Influence of Cationic Amino Acids on the Viscosity and Stability of a Highly Concentrated Monoclonal Antibody
10.1007/s11095-016-2055-5 · 2017 · External reference
High throughput thermostability screening of monoclonal antibody formulations
10.1002/jps.21955 · 2010 · External reference
Bulky Polar Additives That Greatly Reduce the Viscosity of Concentrated Solutions of Therapeutic Monoclonal Antibodies
10.1016/j.xphs.2017.01.018 · 2017 · External reference
10.1002/bit.22983
10.1002/bit.22983 · External reference
Novel salts of dipicolinic acid as viscosity modifiers for high concentration antibody solutions
2018 · External reference
A Formulation Development Approach to Identify and Select Stable Ultra–High-Concentration Monoclonal Antibody Formulations With Reduced Viscosities
10.1016/j.xphs.2017.06.017 · 2017 · External reference
Structure-Activity Relationship for Hydrophobic Salts as Viscosity-Lowering Excipients for Concentrated Solutions of Monoclonal Antibodies
10.1007/s11095-012-0802-9 · 2012 · External reference
Evolution of commercially available compounds for HTS
10.1016/j.drudis.2018.10.016 · 2019 · External reference
Characterization of 30 therapeutic antibodies and related products by size exclusion chromatography: Feasibility assessment for future mass spectrometry hyphenation
10.1016/j.jchromb.2017.09.027 · 2017 · External reference
10.1073/pnas.0904191106
10.1073/pnas.0904191106 · External reference
Determination of isoelectric points and relative charge variants of 23 therapeutic monoclonal antibodies
10.1016/j.jchromb.2017.09.033 · 2017 · External reference
Computational tool for the early screening of monoclonal antibodies for their viscosities
10.1080/19420862.2015.1099773 · 2016 · External reference
10.1016/j.addr.2011.08.003
10.1016/j.addr.2011.08.003 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
10.1007/978-3-540-78246-9_38
10.1007/978-3-540-78246-9_38 · External reference
PAINS in the Assay: Chemical Mechanisms of Assay Interference and Promiscuous Enzymatic Inhibition Observed during a Sulfhydryl-Scavenging HTS
10.1021/jm5019093 · 2015 · External reference
10.1002/cmdc.200700139
10.1002/cmdc.200700139 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
10.1021/acs.jcim.0c00675
10.1021/acs.jcim.0c00675 · External reference
Unresolved reference
External reference
10.1186/1758-2946-3-33
10.1186/1758-2946-3-33 · External reference
Unresolved reference
External reference
Epik: a software program for pKaprediction and protonation state generation for drug-like molecules
10.1007/s10822-007-9133-z · 2007 · External reference
In Silico Tools for Sharing Data and Knowledge on Toxicity and Metabolism: Derek for Windows, Meteor, and Vitic
10.1080/15376510701857320 · 2008 · External reference
Evaluation of the impact of viscosity, injection volume, and injection flow rate on subcutaneous injection tolerance
2015 · External reference
Molecular Similarity in Medicinal Chemistry
10.1021/jm401411z · 2014 · External reference
10.1016/s0169-409x(96)00423-1
10.1016/s0169-409x(96)00423-1 · External reference
ADME Evaluation in Drug Discovery. 2. Prediction of Partition Coefficient by Atom-Additive Approach Based on Atom-Weighted Solvent Accessible Surface Areas
10.1021/ci034007m · 2003 · External reference
Long- and Short-Range Electrostatic Interactions Affect the Rheology of Highly Concentrated Antibody Solutions
10.1007/s11095-009-9975-2 · 2009 · External reference
Development of high concentration protein biopharmaceuticals: The use of platform approaches in formulation development
10.1016/j.ejpb.2011.03.004 · 2011 · External reference
10.1016/j.jcis.2020.06.105
10.1016/j.jcis.2020.06.105 · External reference
Self-Buffering Antibody Formulations
10.1002/jps.21232 · 2008 · External reference
10.1039/9781849733045
10.1039/9781849733045 · 2011 · External reference
Polar Solvents Decrease the Viscosity of High Concentration IgG1 Solutions Through Hydrophobic Solvation and Interaction: Formulation and Biocompatibility Considerations
10.1002/jps.23453 · 2013 · External reference
